Cargando…

Effect of Repaglinide on Blood Glucose, Endothelial Function, Lipid Metabolism, and Inflammatory Reaction in a Rat Model of Atherosclerosis

OBJECTIVE: To investigate the protective effect of repaglinide on rat with atherosclerosis. METHODS: Sprague Dawley (SD) rats were divided into control, model, repaglinide, and metformin groups. In addition to the normal group, rats were given intraperitoneal injection of streptozotocin and high-fat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jie, Liu, Bing, Cheng, Yan-xia, Zhang, Jin-guang, Tao, Shuo, Yan, Hong-ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154560/ https://www.ncbi.nlm.nih.gov/pubmed/32313525 http://dx.doi.org/10.1177/1559325820918762

Ejemplares similares

Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers
por: Yamazaki, Masahiro, et al.
Publicado: (2014)

Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance
por: Schmoelzer, Isabella, et al.
Publicado: (2006)

Glucose-dependent and Glucose-sensitizing Insulinotropic Effect of Nateglinide: Comparison to Sulfonylureas and Repaglinide
por: Hu, Shiling, et al.
Publicado: (2001)

Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea
por: Omori, Kazuno, et al.
Publicado: (2018)

Repaglinide-Induced Acute Pancreatitis
por: Udongwo, Ndausung, et al.
Publicado: (2021)

Formulation and Evaluation of Transdermal Patch of Repaglinide
por: Prajapati, Shailesh T., et al.
Publicado: (2011)

Clinical Effects of Exercise Rehabilitation Combined with Repaglinide in the Treatment of Diabetes
por: Li, Yan, et al.
Publicado: (2022)

Evaluation of the effects of glimepiride (Amaryl) and repaglinide (novoNorm) on atherosclerosis progression in high cholesterol-fed male rabbits
por: Hadi, Najah R., et al.
Publicado: (2012)

Clinical study of repaglinide efficacy and safety in type 2 diabetes mellitus patients with blood glucose levels inadequately controlled by sitagliptin
por: Kawamori, Ryuzo, et al.
Publicado: (2015)

Comparative Study of the Antioxidant Effects of Metformin, Glibenclamide, and Repaglinide in Alloxan-Induced Diabetic Rats
por: Chukwunonso Obi, Bonaventure, et al.
Publicado: (2016)

Development of Spectrofluorimetric and HPLC Methods for In vitro Analysis of Repaglinide
por: Kaushal, N., et al.
Publicado: (2010)

Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles
por: Ebrahimi, Hossein Ali, et al.
Publicado: (2015)

Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus
por: Wang, Liang-Chen, et al.
Publicado: (2018)

Correlation of cathepsin S with coronary stenosis degree, carotid thickness, blood pressure, glucose and lipid metabolism and vascular endothelial function in atherosclerosis
por: Huang, Shengyang, et al.
Publicado: (2020)

Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and in situ intestinal perfusion
por: Wu, Lei, et al.
Publicado: (2019)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
por: Moses, Robert
Publicado: (2009)

Sex hormones affect endothelial lipase-mediated lipid metabolism and atherosclerosis
por: Wang, Chuan, et al.
Publicado: (2019)

Severe Thrombocytopenia Due to Repaglinide in a Patient With Type 2 Diabetes
por: Katsuyama, Hisayuki, et al.
Publicado: (2013)

Interaction of repaglinide with bovine serum albumin: Spectroscopic and molecular docking approaches
por: Pawar, Suma K., et al.
Publicado: (2019)

Repaglinide, but Not Nateglinide Administered Supraspinally and Spinally Exerts an Anti-Diabetic Action in D-Glucose Fed and Streptozotocin-Treated Mouse Models
por: Sim, Yun-Beom, et al.
Publicado: (2013)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
por: Ma, J., et al.
Publicado: (2014)

Adipose-Derived Stem Cell Transplantation Inhibits Vascular Inflammatory Responses and Endothelial Dysfunction in Rats with Atherosclerosis
por: Fan, Mingqiang, et al.
Publicado: (2019)

The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
por: Guardado-Mendoza, Rodolfo, et al.
Publicado: (2013)

The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy
por: Tanaka, Kenichi, et al.
Publicado: (2017)

Risk of hypoglycemia associated with repaglinide combined with clopidogrel, a retrospective cohort study
por: Akagi, Yuuki, et al.
Publicado: (2020)

Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports
por: Razzaghy-Azar, Maryam, et al.
Publicado: (2021)

Development of Novel S-Protective Thiolated-Based Mucoadhesive Tablets for Repaglinide: Pharmacokinetic Study
por: Alhakamy, Nabil A., et al.
Publicado: (2022)

Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes
por: Ahmad, Mubashir, et al.
Publicado: (2023)

Characterization of binding by repaglinide and nateglinide with glycated human serum albumin using high‐performance affinity microcolumns
por: Ovbude, Susan T., et al.
Publicado: (2022)

MTNR1B Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus
por: Wang, Tao, et al.
Publicado: (2019)

A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients
por: Zhou, Xueyan, et al.
Publicado: (2016)

Comparison of UV spectrophotometry and high performance liquid chromatography methods for the determination of repaglinide in tablets
por: Dhole, Seema M., et al.
Publicado: (2012)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus
por: Younas, Amna, et al.
Publicado: (2021)

Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats
por: Fouad, Shahinaze A., et al.
Publicado: (2023)

The Effect of Resveratrol on Blood Glucose and Blood Lipids in Rats with Gestational Diabetes Mellitus
por: Zhang, Guanli, et al.
Publicado: (2021)

A novel drug–drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide
por: Su, Meiling, et al.
Publicado: (2020)

Inflammatory and Autoimmune Reactions in Atherosclerosis and Vaccine Design Informatics
por: Jan, Michael, et al.
Publicado: (2010)

The more critical murderer of atherosclerosis than lipid metabolism: chronic stress
por: Meng, Ling-bing, et al.
Publicado: (2018)

Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2012)

Antioxidant properties of repaglinide and its protections against cyclosporine A-induced renal tubular injury
por: Li, Dao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u0p2lvtv3gap9b16cq4bdacfs2